Curaleaf CEO Matt Darin discusses growth of the cannabis business and Twitter now allowing cannabis ads. 
Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan. 

Curaleaf CEO Matt Darin discusses growth of the cannabis business and Twitter now allowing cannabis ads. Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Curaleaf CEO Sees Immense Demand in Florida

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/02827f84-b8d0-4e77-b2d1-afb100cd7a18/transcript

The people, companies and trends shaping the global economy.

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

Oracle Corp. and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI’s changing needs.

The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., the leading AI chipmaker, helped facilitate Meta’s discussions with the developer, said the people, who asked not to be identified because the talks are private.

The shifting plans underscore the complexity of building out AI data centers, which are expected to cost in the tens of billions of dollars and require cooperation from a wide swath of partners.

The campus being developed by Crusoe in Abilene is part of the highly publicized Stargate project, which was announced last year at the White House with President Donald Trump. While the 1,000-acre site continues to be built, and several parts are up and running, Oracle and OpenAI elected not to go forward with tentative plans to lease a large expansion, the people said.

Oracle and OpenAI are using Nvidia’s AI semiconductors at the Stargate site. With Crusoe seeking a tenant, Nvidia became involved to ensure its products would still fill the expanded data center rather than that of rival Advanced Micro Devices Inc., said the people. Nvidia paid a $150 million deposit to Crusoe and began helping court Meta as a tenant for the expansion, the people said.
Today's show features:
Ed Ludlow, Bloomberg Tech co-host on Oracle and OpenAI End Plans to Expand Flagship Data Center
Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council, on oil markets
James Crombie, Bloomberg News Senior Editor on Credit, on how broad credit markers are reacting to war and inflation
Drive to the Close with Sevasti Balafas, CEO at GoalVest Advisory

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube:&nbsp;<a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.
Oracle Corp. and OpenAI have scrapped plans to expand a flagship artificial intelligence data center in Texas after negotiations dragged over financing and OpenAI&rsquo;s changing needs.
The collapsed talks created an opening for Meta Platforms Inc. to step in and consider leasing the planned expansion site in Abilene, Texas, from developer Crusoe, according to people familiar with the matter. Nvidia Corp., the leading AI chipmaker, helped facilitate Meta&rsquo;s discussions with the developer, said the people, who asked not to be identified because the talks are private.
The shifting plans underscore the complexity of building out AI data centers, which are expected to cost in the tens of billions of dollars and require cooperation from a wide swath of partners.
The campus being developed by Crusoe in Abilene is part of the highly publicized Stargate project, which was announced last year at the White House with President Donald Trump. While the 1,000-acre site continues to be built, and several parts are up and running, Oracle and OpenAI elected not to go forward with tentative plans to lease a large expansion, the people said.
Oracle and OpenAI are using Nvidia&rsquo;s AI semiconductors at the Stargate site. With Crusoe seeking a tenant, Nvidia became involved to ensure its products would still fill the expanded data center rather than that of rival Advanced Micro Devices Inc., said the people. Nvidia paid a $150 million deposit to Crusoe and began helping court Meta as a tenant for the expansion, the people said. Today's show features:
<ul>
<li>Ed Ludlow, Bloomberg Tech co-host on Oracle and OpenAI End Plans to Expand Flagship Data Center</li>
<li>Ellen Wald, President of Transversal Consulting and Senior Fellow at the Atlantic Council, on oil markets</li>
<li>James Crombie, Bloomberg News Senior Editor on Credit, on how broad credit markers are reacting to war and inflation</li>
<li>Drive to the Close with Sevasti Balafas, CEO at GoalVest Advisory</li>
</ul>

Oracle and OpenAI End Plans to Expand Flagship Data Center

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fa4b212b-3ebc-4184-bc06-b4050178b530/transcript

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. They are focused on becoming the standard of care for spine fusion surgery. They've been using technology and AI-enabled 3D surgical planning and implants personalized for each patient.

Mike Cordonnier is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors. He speaks with Carol Massar and Tim Stenovec on the company's earnings and commercial & growth strategy.

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. They are focused on becoming the standard of care for spine fusion surgery. They've been using technology and AI-enabled 3D surgical planning and implants personalized for each patient.
Mike Cordonnier is the co-founder and serves as Chief Executive Officer and President of Carlsmed, he also serves as Chairman of the Board of Directors. He speaks with Carol Massar and Tim Stenovec on the company's earnings and commercial &amp; growth strategy.

Carlsmed CEO on Cutting-Edge Spinal Care Technology  

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b87da615-108a-4c2f-9505-b4050172079c/transcript

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy, according to a new study by researchers at Weill Cornell Medicine and the University of Virginia School of Medicine. These molecules influence the brain’s stress response and emotional regulation.

Dr. Lauren Osborne is Vice Chair of Clinical Research, Department of OBGYN at Weill Cornell Medicine and she discusses how postpartum depression affects many families, how common is it, and why has it historically been underdiagnosed or overlooked.

Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood during the third trimester of pregnancy, according to a new study by researchers at Weill Cornell Medicine and the University of Virginia School of Medicine. These molecules influence the brain&rsquo;s stress response and emotional regulation.
Dr. Lauren Osborne is Vice Chair of Clinical Research, Department of OBGYN at Weill Cornell Medicine and she discusses how postpartum depression affects many families, how common is it, and why has it historically been underdiagnosed or overlooked.

Predicting Risk of Postpartum Depression

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/94a6aff9-e373-4e68-b40c-b404016ebd38/transcript

Curaleaf CEO Sees Immense Demand in Florida

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips